期刊文献+

生长抑素治疗肠梗阻的临床研究 被引量:72

Clinical study of somatostatin on intestinal obstruction
原文传递
导出
摘要 目的探讨生长抑素治疗肠梗阻的疗效。方法采用多中心、随机对照方法,将各种不同类型的肠梗阻162例随机分为治疗组和对照组。对照组给予常规治疗,包括禁食、胃肠减压、纠正水电解质和酸碱平衡紊乱,全胃肠外营养以及应用抗生素;治疗组在常规治疗基础上加用生长抑素(思他宁)6mg加生理盐水500ml静脉滴注,维持24h。观察和比较两组治疗前后临床症状及体征改善情况、胃肠减压量、水电解质指标的改变和中转手术率。结果治疗组临床症状明显改善;与对照组相比,腹痛和腹胀的缓解率分别为90.1%、76.5%(P<0.05);肛门恢复排气排便比率分别为88.8%、76.0%(P<0.05);胃肠减压量明显少于对照组,分别为(277±225)ml/d、(564±278)ml/d(P<0.01);中转手术率明显低于对照组,分别为8.7%、19.8%(P<0.05)。结论在常规治疗基础上,应用生长抑素治疗各种类型肠梗阻,可明显改善临床症状,提高保守治疗的成功率。 Objective To investigate the effects of somatostatin on intestinal obstruction. Methods One hundred and sixty two patients suffering from obstructive ileus were randomly divided into control group and stilamin group. Patients in the control group were treated with routine therapy including gastroenteral decompression,intravenous replacement of fluid and electrolytes,total parenteral nutrition and antibiotics. Patients in the stilamin group received continuous infusion of stilamin (6 mg/d) intravenously plus routine therapy. Results Two to seven days after treatment,the clinical symptoms were significantly improved in stilamin group,the average volume of gastroenteral decompression reduced in stilamin group compared to the control group(277±225)ml/d vs(564±278 )ml/d(P< 0.01). The rate of transferring to operation in stilamin group (8.69%) was significantly lower than that in the control group (19.8%)(P< 0.05). Conclusions Stilamin combined with routine treatment is an effective method to treat intestinal obstruction such as early postoperative inflammatory small bowel obstruction(EPISBO),adhensive bowel obstruction,pseudo colon obstruction and malignant bowel obstruction.
出处 《中华胃肠外科杂志》 CAS 2004年第6期474-476,共3页 Chinese Journal of Gastrointestinal Surgery
关键词 生长抑素 治疗 肠梗阻 临床研究 Somatostatin Intestinal obstruction Efficacy
  • 相关文献

参考文献7

  • 1Strowski MZ,Parmar RM,Blake AD,et al. Somatostatin inhibits insulin and glucagons secretion via two receptors subtypes:an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice. Endocrinology,2000,141:111-117.
  • 2Gong AY,Tietz PS,Muff MA,et al. Somatostatin stimulates ductal bile absorption and inhibits ductal bile secretion in mice via SSTR2 on cholangiocytes. Am J Cell Physiol,2003,284:1205-1214.
  • 3黎介寿,任建安,王新波,顾军,姜军.生长抑素与生长激素促进肠外瘘自愈的机理与临床研究[J].中华外科杂志,2000,38(6):447-450. 被引量:167
  • 4Ripamonti C,Panzeri C,Groff L,et al. The role of somatostatin and octreotide in bowel obstruction: pre-clinical and clinical results. Tumori,2001,87:1-9.
  • 5Mulvihill SJ,Pappas TN,Fonkalsrud EW,et al. The effect of somatostatin on experimental intestinal obstruction. Ann Surg,1988,207:169-173.
  • 6Bastounis E,Hadjinikolaou L,Ioannou N,et al. Somatostatin as adjuvant therapy in the management of obstructive ileus. Hepatogastroenterology,1989,36:538-539.
  • 7朱维铭,李宁,黎介寿,尹路,任建安,顾军,姜军,王少华,王新波.术后早期炎性肠梗阻的治疗[J].中国实用外科杂志,2002,22(4):219-220. 被引量:276

二级参考文献5

共引文献436

同被引文献438

引证文献72

二级引证文献443

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部